Uncovering Novel Microenvironmental Targets for Radiopharmaceutical Development
Time: 1:15 pm
day: Day Two Discovery PM
Details:
- Targeting stromal cells in tumor and metastatic masses, attractive targets for radiopharmaceutical ablation
- Evaluating a novel high affinity antibody platform targeting LRRC15 in preclinical systems
- Exploring cross reaction with humans for targeted imaging and therapy of aggressive treatment refractory cancers of mesenchymal lineage
